

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sphingosine metabolic process (GO:0006670) | 7.36485871 |
| 2 | diol metabolic process (GO:0034311) | 6.56872149 |
| 3 | meiotic chromosome segregation (GO:0045132) | 6.51242656 |
| 4 | behavioral response to nicotine (GO:0035095) | 6.37740752 |
| 5 | sphingoid metabolic process (GO:0046519) | 6.34846510 |
| 6 | positive regulation of meiosis (GO:0045836) | 5.23459881 |
| 7 | regulation of meiosis I (GO:0060631) | 4.96668774 |
| 8 | positive regulation of meiotic cell cycle (GO:0051446) | 4.84202144 |
| 9 | piRNA metabolic process (GO:0034587) | 4.60868440 |
| 10 | response to pheromone (GO:0019236) | 4.55308094 |
| 11 | negative regulation of telomere maintenance (GO:0032205) | 4.52153089 |
| 12 | DNA methylation involved in gamete generation (GO:0043046) | 4.49607635 |
| 13 | sulfate transmembrane transport (GO:1902358) | 4.40685992 |
| 14 | DNA deamination (GO:0045006) | 4.35993736 |
| 15 | neurotransmitter metabolic process (GO:0042133) | 4.29942311 |
| 16 | protein-chromophore linkage (GO:0018298) | 4.19929978 |
| 17 | organic cation transport (GO:0015695) | 4.18072394 |
| 18 | sulfate transport (GO:0008272) | 4.17450302 |
| 19 | neurotransmitter biosynthetic process (GO:0042136) | 4.14811429 |
| 20 | kynurenine metabolic process (GO:0070189) | 4.10053591 |
| 21 | drug transmembrane transport (GO:0006855) | 4.04099587 |
| 22 | lipopolysaccharide biosynthetic process (GO:0009103) | 4.01531527 |
| 23 | reciprocal DNA recombination (GO:0035825) | 3.88336547 |
| 24 | reciprocal meiotic recombination (GO:0007131) | 3.88336547 |
| 25 | indole-containing compound catabolic process (GO:0042436) | 3.82187065 |
| 26 | indolalkylamine catabolic process (GO:0046218) | 3.82187065 |
| 27 | tryptophan catabolic process (GO:0006569) | 3.82187065 |
| 28 | rRNA catabolic process (GO:0016075) | 3.78317542 |
| 29 | sulfation (GO:0051923) | 3.73886208 |
| 30 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 3.65151734 |
| 31 | histamine transport (GO:0051608) | 3.62464513 |
| 32 | exogenous drug catabolic process (GO:0042738) | 3.60525626 |
| 33 | aromatic amino acid family catabolic process (GO:0009074) | 3.59318042 |
| 34 | resolution of meiotic recombination intermediates (GO:0000712) | 3.56429077 |
| 35 | histone-serine phosphorylation (GO:0035404) | 3.53572238 |
| 36 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.53338331 |
| 37 | indolalkylamine metabolic process (GO:0006586) | 3.50086036 |
| 38 | cellular ketone body metabolic process (GO:0046950) | 3.41936957 |
| 39 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.34909333 |
| 40 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.34687418 |
| 41 | adaptation of signaling pathway (GO:0023058) | 3.34461131 |
| 42 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.33590392 |
| 43 | L-phenylalanine catabolic process (GO:0006559) | 3.33590392 |
| 44 | C4-dicarboxylate transport (GO:0015740) | 3.31859417 |
| 45 | lipopolysaccharide metabolic process (GO:0008653) | 3.31504265 |
| 46 | protein K11-linked deubiquitination (GO:0035871) | 3.29082091 |
| 47 | positive regulation of fatty acid oxidation (GO:0046321) | 3.27635907 |
| 48 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.26282241 |
| 49 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.26147840 |
| 50 | sulfur compound transport (GO:0072348) | 3.25353162 |
| 51 | regulation of pigment cell differentiation (GO:0050932) | 3.22170192 |
| 52 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.17267164 |
| 53 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.16542347 |
| 54 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.11656277 |
| 55 | regulation of protein glycosylation (GO:0060049) | 3.11583679 |
| 56 | drug catabolic process (GO:0042737) | 3.08617381 |
| 57 | auditory receptor cell stereocilium organization (GO:0060088) | 3.07586712 |
| 58 | ketone body metabolic process (GO:1902224) | 3.03995122 |
| 59 | flavonoid metabolic process (GO:0009812) | 3.03133162 |
| 60 | negative regulation by host of viral transcription (GO:0043922) | 3.02957699 |
| 61 | tryptophan metabolic process (GO:0006568) | 3.02381207 |
| 62 | gamma-aminobutyric acid transport (GO:0015812) | 3.01138360 |
| 63 | positive regulation of developmental pigmentation (GO:0048087) | 2.98250593 |
| 64 | quaternary ammonium group transport (GO:0015697) | 2.96405477 |
| 65 | tooth mineralization (GO:0034505) | 2.96287269 |
| 66 | cornea development in camera-type eye (GO:0061303) | 2.96261334 |
| 67 | rhodopsin mediated signaling pathway (GO:0016056) | 2.96016587 |
| 68 | gonadal mesoderm development (GO:0007506) | 2.95567338 |
| 69 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.95155632 |
| 70 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.91848881 |
| 71 | aromatic amino acid family metabolic process (GO:0009072) | 2.88250207 |
| 72 | regulation of activation of Janus kinase activity (GO:0010533) | 2.87486923 |
| 73 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.86972303 |
| 74 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.85473695 |
| 75 | detection of light stimulus involved in visual perception (GO:0050908) | 2.85473695 |
| 76 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.83957558 |
| 77 | primary amino compound metabolic process (GO:1901160) | 2.82107558 |
| 78 | fucose catabolic process (GO:0019317) | 2.80794267 |
| 79 | L-fucose metabolic process (GO:0042354) | 2.80794267 |
| 80 | L-fucose catabolic process (GO:0042355) | 2.80794267 |
| 81 | proline transport (GO:0015824) | 2.80203961 |
| 82 | coenzyme catabolic process (GO:0009109) | 2.79840359 |
| 83 | cellular biogenic amine catabolic process (GO:0042402) | 2.75844845 |
| 84 | amine catabolic process (GO:0009310) | 2.75844845 |
| 85 | indole-containing compound metabolic process (GO:0042430) | 2.74856544 |
| 86 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.69971009 |
| 87 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.69606954 |
| 88 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.69136373 |
| 89 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.69136373 |
| 90 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.68703044 |
| 91 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.67976010 |
| 92 | cytidine deamination (GO:0009972) | 2.65575777 |
| 93 | cytidine metabolic process (GO:0046087) | 2.65575777 |
| 94 | cytidine catabolic process (GO:0006216) | 2.65575777 |
| 95 | tachykinin receptor signaling pathway (GO:0007217) | 2.62750934 |
| 96 | signal peptide processing (GO:0006465) | 2.60738454 |
| 97 | synaptonemal complex assembly (GO:0007130) | 2.59764087 |
| 98 | azole transport (GO:0045117) | 2.58980387 |
| 99 | cellular response to exogenous dsRNA (GO:0071360) | 2.58917330 |
| 100 | tyrosine metabolic process (GO:0006570) | 2.58554958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.37706067 |
| 2 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.56277704 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.41407411 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.96518996 |
| 5 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.76552187 |
| 6 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.48877450 |
| 7 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.37152383 |
| 8 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.34829450 |
| 9 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.29167809 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.14891365 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.12470925 |
| 12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.10988267 |
| 13 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.03027361 |
| 14 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.91245083 |
| 15 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.91245083 |
| 16 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.89479596 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.82612946 |
| 18 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.78254057 |
| 19 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.77320116 |
| 20 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.73716180 |
| 21 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.73047723 |
| 22 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.72854378 |
| 23 | P300_19829295_ChIP-Seq_ESCs_Human | 1.72482318 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.70192441 |
| 25 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.62550485 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61328283 |
| 27 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.56860860 |
| 28 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.55887880 |
| 29 | NCOR_22424771_ChIP-Seq_293T_Human | 1.46304139 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.44244007 |
| 31 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.44212351 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.44202379 |
| 33 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.43083193 |
| 34 | TCF4_23295773_ChIP-Seq_U87_Human | 1.41746621 |
| 35 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.37518866 |
| 36 | STAT3_23295773_ChIP-Seq_U87_Human | 1.36302226 |
| 37 | AR_25329375_ChIP-Seq_VCAP_Human | 1.36281914 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.35703825 |
| 39 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.34628000 |
| 40 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.34607186 |
| 41 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.33738918 |
| 42 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.32106160 |
| 43 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.31306435 |
| 44 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.29682588 |
| 45 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.29497009 |
| 46 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.29497009 |
| 47 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.28095663 |
| 48 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.24741380 |
| 49 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.23194085 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22296428 |
| 51 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.21979182 |
| 52 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.21533377 |
| 53 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.21336249 |
| 54 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.21336249 |
| 55 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.20822457 |
| 56 | AR_20517297_ChIP-Seq_VCAP_Human | 1.20735771 |
| 57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.20353327 |
| 58 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.19951511 |
| 59 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.19866228 |
| 60 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.19251369 |
| 61 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.18413318 |
| 62 | EWS_26573619_Chip-Seq_HEK293_Human | 1.18275038 |
| 63 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.17859861 |
| 64 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.17361103 |
| 65 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.17161983 |
| 66 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.16798541 |
| 67 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.16623205 |
| 68 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.16043326 |
| 69 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15672883 |
| 70 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.15672883 |
| 71 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13993657 |
| 72 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.13021434 |
| 73 | FUS_26573619_Chip-Seq_HEK293_Human | 1.12531709 |
| 74 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12414131 |
| 75 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.12293505 |
| 76 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11887168 |
| 77 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.11862434 |
| 78 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.10693486 |
| 79 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.10685591 |
| 80 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09836835 |
| 81 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.09492961 |
| 82 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.09348002 |
| 83 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.08298231 |
| 84 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.07352336 |
| 85 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.07129743 |
| 86 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06542555 |
| 87 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.06516628 |
| 88 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.05637363 |
| 89 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.04913915 |
| 90 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.04700577 |
| 91 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.03751095 |
| 92 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.02224741 |
| 93 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.01645456 |
| 94 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01582262 |
| 95 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.01559568 |
| 96 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01263432 |
| 97 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.00795455 |
| 98 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00282326 |
| 99 | ERA_21632823_ChIP-Seq_H3396_Human | 1.00134021 |
| 100 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.99740134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 5.86205437 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.63186514 |
| 3 | MP0003646_muscle_fatigue | 4.94563115 |
| 4 | MP0005171_absent_coat_pigmentation | 3.40436125 |
| 5 | MP0003045_fibrosis | 2.96949390 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.94200853 |
| 7 | MP0003195_calcinosis | 2.54045330 |
| 8 | MP0002653_abnormal_ependyma_morphology | 2.48999830 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.47110247 |
| 10 | MP0001501_abnormal_sleep_pattern | 2.33202285 |
| 11 | MP0005551_abnormal_eye_electrophysiolog | 2.31286095 |
| 12 | MP0004381_abnormal_hair_follicle | 2.19752101 |
| 13 | MP0004147_increased_porphyrin_level | 2.15998429 |
| 14 | MP0008872_abnormal_physiological_respon | 2.03827798 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 1.99473287 |
| 16 | MP0004043_abnormal_pH_regulation | 1.88311265 |
| 17 | MP0001968_abnormal_touch/_nociception | 1.85025901 |
| 18 | MP0003879_abnormal_hair_cell | 1.84212580 |
| 19 | MP0001873_stomach_inflammation | 1.82651222 |
| 20 | MP0005365_abnormal_bile_salt | 1.81151614 |
| 21 | MP0002160_abnormal_reproductive_system | 1.80388554 |
| 22 | MP0003011_delayed_dark_adaptation | 1.79731055 |
| 23 | MP0005671_abnormal_response_to | 1.77663666 |
| 24 | MP0008875_abnormal_xenobiotic_pharmacok | 1.71166874 |
| 25 | MP0005410_abnormal_fertilization | 1.60499642 |
| 26 | MP0000372_irregular_coat_pigmentation | 1.54398803 |
| 27 | MP0006276_abnormal_autonomic_nervous | 1.48884661 |
| 28 | MP0004142_abnormal_muscle_tone | 1.47770185 |
| 29 | MP0005670_abnormal_white_adipose | 1.47573214 |
| 30 | MP0009745_abnormal_behavioral_response | 1.44589844 |
| 31 | MP0009046_muscle_twitch | 1.42875784 |
| 32 | MP0005645_abnormal_hypothalamus_physiol | 1.40440580 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.40338338 |
| 34 | MP0002733_abnormal_thermal_nociception | 1.40037061 |
| 35 | MP0003137_abnormal_impulse_conducting | 1.38451600 |
| 36 | MP0002168_other_aberrant_phenotype | 1.36134475 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.32412205 |
| 38 | MP0002736_abnormal_nociception_after | 1.27841963 |
| 39 | MP0005389_reproductive_system_phenotype | 1.25706453 |
| 40 | MP0005075_abnormal_melanosome_morpholog | 1.25633613 |
| 41 | MP0000569_abnormal_digit_pigmentation | 1.22372424 |
| 42 | MP0005253_abnormal_eye_physiology | 1.20280530 |
| 43 | MP0004145_abnormal_muscle_electrophysio | 1.17510887 |
| 44 | MP0000427_abnormal_hair_cycle | 1.17029945 |
| 45 | MP0002938_white_spotting | 1.16951101 |
| 46 | MP0006072_abnormal_retinal_apoptosis | 1.14662484 |
| 47 | MP0003252_abnormal_bile_duct | 1.13690974 |
| 48 | MP0001970_abnormal_pain_threshold | 1.13038427 |
| 49 | MP0001986_abnormal_taste_sensitivity | 1.12067424 |
| 50 | MP0004742_abnormal_vestibular_system | 1.11563496 |
| 51 | MP0001486_abnormal_startle_reflex | 1.10431995 |
| 52 | MP0003890_abnormal_embryonic-extraembry | 1.09616370 |
| 53 | MP0005360_urolithiasis | 1.07129209 |
| 54 | MP0002095_abnormal_skin_pigmentation | 1.05811191 |
| 55 | MP0002272_abnormal_nervous_system | 1.05030311 |
| 56 | MP0001485_abnormal_pinna_reflex | 1.03772173 |
| 57 | MP0001664_abnormal_digestion | 1.03610840 |
| 58 | MP0001764_abnormal_homeostasis | 1.03494830 |
| 59 | MP0002735_abnormal_chemical_nociception | 1.03383645 |
| 60 | MP0004130_abnormal_muscle_cell | 1.01539347 |
| 61 | MP0002102_abnormal_ear_morphology | 0.99830845 |
| 62 | MP0001963_abnormal_hearing_physiology | 0.98270587 |
| 63 | MP0002064_seizures | 0.96904771 |
| 64 | MP0002638_abnormal_pupillary_reflex | 0.93336465 |
| 65 | MP0005266_abnormal_metabolism | 0.92081400 |
| 66 | MP0004019_abnormal_vitamin_homeostasis | 0.89009892 |
| 67 | MP0010386_abnormal_urinary_bladder | 0.86873811 |
| 68 | MP0002163_abnormal_gland_morphology | 0.86769490 |
| 69 | MP0002572_abnormal_emotion/affect_behav | 0.86249130 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 0.85281033 |
| 71 | MP0000230_abnormal_systemic_arterial | 0.84402835 |
| 72 | MP0002876_abnormal_thyroid_physiology | 0.83877416 |
| 73 | MP0008877_abnormal_DNA_methylation | 0.83368079 |
| 74 | MP0001919_abnormal_reproductive_system | 0.83065457 |
| 75 | MP0003698_abnormal_male_reproductive | 0.82409335 |
| 76 | MP0005395_other_phenotype | 0.82198945 |
| 77 | MP0006036_abnormal_mitochondrial_physio | 0.81914086 |
| 78 | MP0002210_abnormal_sex_determination | 0.80578859 |
| 79 | MP0005084_abnormal_gallbladder_morpholo | 0.77714037 |
| 80 | MP0001800_abnormal_humoral_immune | 0.75400399 |
| 81 | MP0003763_abnormal_thymus_physiology | 0.75183695 |
| 82 | MP0005646_abnormal_pituitary_gland | 0.74612468 |
| 83 | MP0004233_abnormal_muscle_weight | 0.73370186 |
| 84 | MP0002229_neurodegeneration | 0.72335611 |
| 85 | MP0003183_abnormal_peptide_metabolism | 0.71806595 |
| 86 | MP0005195_abnormal_posterior_eye | 0.70993304 |
| 87 | MP0009764_decreased_sensitivity_to | 0.70164949 |
| 88 | MP0010329_abnormal_lipoprotein_level | 0.69338201 |
| 89 | MP0005174_abnormal_tail_pigmentation | 0.69258124 |
| 90 | MP0005377_hearing/vestibular/ear_phenot | 0.67018043 |
| 91 | MP0003878_abnormal_ear_physiology | 0.67018043 |
| 92 | MP0000631_abnormal_neuroendocrine_gland | 0.66894124 |
| 93 | MP0005448_abnormal_energy_balance | 0.66759082 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.66669350 |
| 95 | MP0003638_abnormal_response/metabolism_ | 0.66426100 |
| 96 | MP0006082_CNS_inflammation | 0.65813515 |
| 97 | MP0001440_abnormal_grooming_behavior | 0.63924838 |
| 98 | MP0002693_abnormal_pancreas_physiology | 0.63822160 |
| 99 | MP0003718_maternal_effect | 0.62905195 |
| 100 | MP0001790_abnormal_immune_system | 0.62524159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 4.37940040 |
| 2 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.35932177 |
| 3 | Hypoplasia of the fovea (HP:0007750) | 4.35932177 |
| 4 | Amelogenesis imperfecta (HP:0000705) | 4.22029891 |
| 5 | Unilateral renal agenesis (HP:0000122) | 4.21546531 |
| 6 | Pancreatic cysts (HP:0001737) | 3.82959874 |
| 7 | Aplastic anemia (HP:0001915) | 3.81939664 |
| 8 | Abnormality of the renal cortex (HP:0011035) | 3.78477048 |
| 9 | Progressive inability to walk (HP:0002505) | 3.68151029 |
| 10 | Decreased central vision (HP:0007663) | 3.48844511 |
| 11 | Focal motor seizures (HP:0011153) | 3.45717240 |
| 12 | Abnormality of the fovea (HP:0000493) | 3.45195804 |
| 13 | Abolished electroretinogram (ERG) (HP:0000550) | 3.27442134 |
| 14 | Pendular nystagmus (HP:0012043) | 3.21613430 |
| 15 | Tubular atrophy (HP:0000092) | 3.21604193 |
| 16 | 3-Methylglutaconic aciduria (HP:0003535) | 3.19713344 |
| 17 | Increased corneal curvature (HP:0100692) | 3.12520439 |
| 18 | Keratoconus (HP:0000563) | 3.12520439 |
| 19 | Attenuation of retinal blood vessels (HP:0007843) | 3.07192438 |
| 20 | Congenital stationary night blindness (HP:0007642) | 3.06862127 |
| 21 | Conjugated hyperbilirubinemia (HP:0002908) | 3.04163040 |
| 22 | Nephronophthisis (HP:0000090) | 3.01914665 |
| 23 | True hermaphroditism (HP:0010459) | 3.01493353 |
| 24 | Inability to walk (HP:0002540) | 2.95381707 |
| 25 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.93518517 |
| 26 | Abnormality of midbrain morphology (HP:0002418) | 2.90100369 |
| 27 | Molar tooth sign on MRI (HP:0002419) | 2.90100369 |
| 28 | Pancreatic fibrosis (HP:0100732) | 2.79800391 |
| 29 | Severe visual impairment (HP:0001141) | 2.75086122 |
| 30 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.68401910 |
| 31 | Abnormality of the renal medulla (HP:0100957) | 2.66330150 |
| 32 | Abnormal drinking behavior (HP:0030082) | 2.62510610 |
| 33 | Polydipsia (HP:0001959) | 2.62510610 |
| 34 | Lissencephaly (HP:0001339) | 2.61867758 |
| 35 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.60224274 |
| 36 | Hypoalbuminemia (HP:0003073) | 2.58601089 |
| 37 | Abnormal albumin level (HP:0012116) | 2.58601089 |
| 38 | Tubulointerstitial fibrosis (HP:0005576) | 2.56460936 |
| 39 | Colon cancer (HP:0003003) | 2.53006201 |
| 40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.50960456 |
| 41 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.49583355 |
| 42 | Gaze-evoked nystagmus (HP:0000640) | 2.47484976 |
| 43 | Parakeratosis (HP:0001036) | 2.45527055 |
| 44 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.43169759 |
| 45 | Decreased circulating renin level (HP:0003351) | 2.40158642 |
| 46 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.35169529 |
| 47 | Cystic liver disease (HP:0006706) | 2.32219998 |
| 48 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.27541971 |
| 49 | Hypoproteinemia (HP:0003075) | 2.27280233 |
| 50 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.25569920 |
| 51 | Type I transferrin isoform profile (HP:0003642) | 2.24592301 |
| 52 | Type II lissencephaly (HP:0007260) | 2.22204006 |
| 53 | Congenital hepatic fibrosis (HP:0002612) | 2.16719479 |
| 54 | Hydroxyprolinuria (HP:0003080) | 2.16580729 |
| 55 | Abnormality of proline metabolism (HP:0010907) | 2.16580729 |
| 56 | Cerebellar dysplasia (HP:0007033) | 2.15454750 |
| 57 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.11564555 |
| 58 | Autoimmune hemolytic anemia (HP:0001890) | 2.10442969 |
| 59 | Renal cortical cysts (HP:0000803) | 2.07440669 |
| 60 | CNS hypomyelination (HP:0003429) | 2.03431603 |
| 61 | Central scotoma (HP:0000603) | 2.02955136 |
| 62 | Abnormal protein glycosylation (HP:0012346) | 2.01256846 |
| 63 | Abnormal glycosylation (HP:0012345) | 2.01256846 |
| 64 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.01256846 |
| 65 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.01256846 |
| 66 | Furrowed tongue (HP:0000221) | 2.01246257 |
| 67 | IgG deficiency (HP:0004315) | 1.98136402 |
| 68 | Sensory axonal neuropathy (HP:0003390) | 1.97507710 |
| 69 | Hyperglycinuria (HP:0003108) | 1.96146108 |
| 70 | Polyuria (HP:0000103) | 1.96135674 |
| 71 | Abnormality of alanine metabolism (HP:0010916) | 1.95317595 |
| 72 | Hyperalaninemia (HP:0003348) | 1.95317595 |
| 73 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.95317595 |
| 74 | Progressive cerebellar ataxia (HP:0002073) | 1.93545565 |
| 75 | Abnormality of macular pigmentation (HP:0008002) | 1.93380219 |
| 76 | Stomach cancer (HP:0012126) | 1.93335375 |
| 77 | Increased cerebral lipofuscin (HP:0011813) | 1.88173102 |
| 78 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86551999 |
| 79 | Concave nail (HP:0001598) | 1.86118960 |
| 80 | Abnormality of the pons (HP:0007361) | 1.85234021 |
| 81 | Radial bowing (HP:0002986) | 1.83714788 |
| 82 | Constricted visual fields (HP:0001133) | 1.83256012 |
| 83 | Hypoplasia of the pons (HP:0012110) | 1.82385154 |
| 84 | Generalized aminoaciduria (HP:0002909) | 1.81942218 |
| 85 | Severe muscular hypotonia (HP:0006829) | 1.81741852 |
| 86 | Acanthocytosis (HP:0001927) | 1.81703895 |
| 87 | Macular degeneration (HP:0000608) | 1.80313230 |
| 88 | Cerebral palsy (HP:0100021) | 1.76750169 |
| 89 | Partial agenesis of the corpus callosum (HP:0001338) | 1.73459447 |
| 90 | Retinitis pigmentosa (HP:0000510) | 1.72808855 |
| 91 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.72534908 |
| 92 | Thyroid-stimulating hormone excess (HP:0002925) | 1.72436352 |
| 93 | Aplasia cutis congenita (HP:0001057) | 1.72212652 |
| 94 | Abnormality of the prostate (HP:0008775) | 1.70939113 |
| 95 | Photophobia (HP:0000613) | 1.70604741 |
| 96 | Clumsiness (HP:0002312) | 1.70389188 |
| 97 | Mixed hearing impairment (HP:0000410) | 1.70270989 |
| 98 | Pigmentary retinal degeneration (HP:0001146) | 1.69836914 |
| 99 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.68883649 |
| 100 | Short tibia (HP:0005736) | 1.68513880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 4.93591598 |
| 2 | STK38L | 4.40739656 |
| 3 | FRK | 4.23700778 |
| 4 | ZAK | 3.26997486 |
| 5 | TXK | 3.08766161 |
| 6 | ACVR1B | 3.07476076 |
| 7 | RIPK4 | 2.94906040 |
| 8 | TLK1 | 2.94789991 |
| 9 | PINK1 | 2.79219084 |
| 10 | ADRBK2 | 2.69461843 |
| 11 | LATS2 | 2.57103336 |
| 12 | PRKD3 | 2.21910078 |
| 13 | BMPR2 | 2.13725971 |
| 14 | STK38 | 1.99459147 |
| 15 | BMPR1B | 1.95616506 |
| 16 | MELK | 1.88092781 |
| 17 | DAPK2 | 1.87308352 |
| 18 | INSRR | 1.74919855 |
| 19 | KDR | 1.61508468 |
| 20 | NME1 | 1.59376144 |
| 21 | LIMK1 | 1.49420349 |
| 22 | NEK2 | 1.45253871 |
| 23 | GRK1 | 1.40178527 |
| 24 | TAF1 | 1.34561736 |
| 25 | MAP3K7 | 1.32216186 |
| 26 | VRK2 | 1.31044410 |
| 27 | STK3 | 1.29315654 |
| 28 | PRKAA2 | 1.24423843 |
| 29 | VRK1 | 1.20000372 |
| 30 | DAPK1 | 1.18711408 |
| 31 | MAP2K2 | 1.18193957 |
| 32 | CDK19 | 1.16671545 |
| 33 | ADRBK1 | 1.14616286 |
| 34 | MAP3K4 | 1.12107752 |
| 35 | ITK | 1.07009938 |
| 36 | TIE1 | 1.06485077 |
| 37 | TRPM7 | 1.04963028 |
| 38 | BCKDK | 1.02694181 |
| 39 | WNK3 | 1.00055666 |
| 40 | TAOK3 | 0.98186643 |
| 41 | NUAK1 | 0.93648490 |
| 42 | TEC | 0.93303917 |
| 43 | STK11 | 0.92094908 |
| 44 | MAPKAPK5 | 0.91650531 |
| 45 | MAPKAPK3 | 0.89506959 |
| 46 | PIK3CG | 0.85925127 |
| 47 | ERBB3 | 0.83544328 |
| 48 | PTK2B | 0.81076689 |
| 49 | NLK | 0.76012601 |
| 50 | ERBB2 | 0.75179487 |
| 51 | CAMKK2 | 0.73401895 |
| 52 | SYK | 0.72681002 |
| 53 | WNK4 | 0.71553728 |
| 54 | MAPK13 | 0.70979146 |
| 55 | BTK | 0.69898702 |
| 56 | OXSR1 | 0.67412867 |
| 57 | MAP3K11 | 0.66610971 |
| 58 | PRKCG | 0.62709291 |
| 59 | TGFBR1 | 0.59791117 |
| 60 | GRK5 | 0.58496036 |
| 61 | MAP4K1 | 0.56039844 |
| 62 | GRK7 | 0.55720713 |
| 63 | CAMK1 | 0.52946425 |
| 64 | NEK9 | 0.51104672 |
| 65 | MAP2K1 | 0.49748275 |
| 66 | SIK2 | 0.49233164 |
| 67 | TNK2 | 0.48921229 |
| 68 | PRKCQ | 0.48231996 |
| 69 | MAP3K12 | 0.47768338 |
| 70 | MAP3K2 | 0.46961941 |
| 71 | MAP4K2 | 0.46276149 |
| 72 | TESK2 | 0.44455092 |
| 73 | CSNK1A1L | 0.43972428 |
| 74 | PRKAA1 | 0.43546512 |
| 75 | SIK3 | 0.41878570 |
| 76 | PLK4 | 0.41148255 |
| 77 | CAMK2A | 0.40434087 |
| 78 | PIK3CA | 0.40239687 |
| 79 | PRKCE | 0.39614118 |
| 80 | CHEK2 | 0.37955960 |
| 81 | CSF1R | 0.36893738 |
| 82 | PRKCH | 0.36843003 |
| 83 | BCR | 0.35647080 |
| 84 | RPS6KA5 | 0.35181886 |
| 85 | BMX | 0.34243558 |
| 86 | PRKCA | 0.32991610 |
| 87 | PRKACA | 0.31978262 |
| 88 | PDPK1 | 0.31466464 |
| 89 | PLK1 | 0.31419812 |
| 90 | EIF2AK3 | 0.30717162 |
| 91 | PRKCB | 0.29453846 |
| 92 | PIM1 | 0.25028161 |
| 93 | EPHA4 | 0.24600052 |
| 94 | PKN1 | 0.23966072 |
| 95 | CAMK4 | 0.23217680 |
| 96 | CSNK1D | 0.21749301 |
| 97 | EIF2AK1 | 0.21656333 |
| 98 | PRKCI | 0.21648331 |
| 99 | LCK | 0.21492354 |
| 100 | MYLK | 0.21305315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 3.69404026 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.79047971 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.78622247 |
| 4 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.41054564 |
| 5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.31557221 |
| 6 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.29401132 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.24373031 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.04797694 |
| 9 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.00317911 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.97120049 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95779858 |
| 12 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.93910857 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.90596153 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.85875541 |
| 15 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.83740549 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.80186449 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.80030405 |
| 18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.79265682 |
| 19 | ABC transporters_Homo sapiens_hsa02010 | 1.78685952 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.77253827 |
| 21 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.74531085 |
| 22 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.73539825 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.71287663 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.66102455 |
| 25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.63730376 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.57793538 |
| 27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.54175700 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.46525700 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.41036356 |
| 30 | Homologous recombination_Homo sapiens_hsa03440 | 1.37622228 |
| 31 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.36326668 |
| 32 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.30557451 |
| 33 | GABAergic synapse_Homo sapiens_hsa04727 | 1.27883062 |
| 34 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.26404740 |
| 35 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.22109766 |
| 36 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.19213532 |
| 37 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.18641318 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.17824268 |
| 39 | Basal transcription factors_Homo sapiens_hsa03022 | 1.16046664 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.13684259 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.13632944 |
| 42 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.12456888 |
| 43 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.11214451 |
| 44 | Sulfur relay system_Homo sapiens_hsa04122 | 1.08430811 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 1.05932086 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.05479626 |
| 47 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02750577 |
| 48 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.00830315 |
| 49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.99896584 |
| 50 | Salivary secretion_Homo sapiens_hsa04970 | 0.98278590 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.96173473 |
| 52 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.96060044 |
| 53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.94161454 |
| 54 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.94118178 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90033603 |
| 56 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.88120967 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.86177886 |
| 58 | Circadian entrainment_Homo sapiens_hsa04713 | 0.84080774 |
| 59 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.80793117 |
| 60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.80053750 |
| 61 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75480061 |
| 62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.75370231 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74777972 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72828956 |
| 65 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.72794831 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.71742223 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69861809 |
| 68 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.68981854 |
| 69 | Allograft rejection_Homo sapiens_hsa05330 | 0.66854391 |
| 70 | RNA polymerase_Homo sapiens_hsa03020 | 0.65591639 |
| 71 | Purine metabolism_Homo sapiens_hsa00230 | 0.62952881 |
| 72 | Parkinsons disease_Homo sapiens_hsa05012 | 0.62648278 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61934051 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61410462 |
| 75 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.59965776 |
| 76 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.59464699 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59272492 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.56955745 |
| 79 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.55625257 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55605622 |
| 81 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.55334924 |
| 82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53713612 |
| 83 | Bile secretion_Homo sapiens_hsa04976 | 0.53131470 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52405768 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52157066 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.50935380 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50634113 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49433326 |
| 89 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48506119 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47142572 |
| 91 | Insulin secretion_Homo sapiens_hsa04911 | 0.45112909 |
| 92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.44965609 |
| 93 | RNA degradation_Homo sapiens_hsa03018 | 0.44298298 |
| 94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44253326 |
| 95 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.42309911 |
| 96 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41690793 |
| 97 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40005020 |
| 98 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.38880390 |
| 99 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.38502305 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37446786 |

